EP134: Discussing Statin Intolerance With Dr. Karam Kostner

Welcome to my podcast. I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I’m a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist and a private practice of over 10,000 patients. Podcast Summary Introduction Dr. Warrick Bishop, a practicing cardiologist and author, hosts this episode with guest Dr. Karam Kostner, a lipid expert and cardiologist from Queensland. The discussion focuses on statin intolerance—a common concern among patients—exploring its definition, prevalence, and practical management strategies in clinical practice. Key Takeaways: Statin intolerance is defined as the inability to tolerate at least two different statins due to clinical side effects, though true intolerance is less common than patients perceive. Muscle pain occurs in approximately 5% of statin users taking higher doses (atorvastatin 80mg, rosuvastatin 40mg), but most musculoskeletal pain is coincidental rather than statin-caused. Rhabdomyolysis, the most serious muscle-related side effect, is extremely rare (approximately 1 in 10,000 to 1 in 80,000 patients) and involves significant muscle pain with CK elevation of 5-10 fold above normal limits. Statins actually prevent vascular dementia and cognitive decline in most patients; short-term memory loss attributed to statins is extremely rare despite popular concerns. Studies show that in a placebo-controlled challenge, approximately 75% of patients reporting statin intolerance could tolerate statins when blinded, while only 25% experienced genuine side effects. Different statins carry different risk profiles; older statins like fluvastatin and pravastatin show lower muscle-related side effects compared to high-dose atorvastatin and rosuvastatin. While statins may slightly increase glucose levels in pre-diabetic patients, this small risk is offset by cardiovascular benefits in diabetic patients. Clinical management strategies include trying multiple statins at varying doses, using low-dose statins three times weekly, and adding ezetrol to achieve cholesterol targets. Magnesium orotate (800-1200mg daily) is an evidence-based, safe, and cost-effective supplement that reduces statin-related muscle symptoms in many patients. Coenzyme Q10 supplementation may help some patients resistant to magnesium, though conclusive evidence from large trials is limited.